Drug from Scorpion Venom Has Been Approved for Cancer treatment

Dr. Ramon Feliz PhD in Oncology says that Midlife's polarized scorpion serum; Escozine has demonstrated astonishing clinical success and has promising future. Immediate responds of patients are lowering Oncological markers, lowering pain, increase of apatite; better sleep, after three months treatment with Escozine, he observed significant decrease of tumor size in many patients. An eight-year, open-label clinical study involved 8,302 cancer patients representing a wide spectrum of cancer types

Blue scorpion serum showed an 89.5% success rate in the quality of life of subjects in the study. Thousands of stage four cancer patients who were only given months to live are still alive today years after first taking blue scorpion serum. Escozine has been used in combination with chemotherapy, radiation and other conventional treatments.

According to Dr. Ramon Feliz Escozine will very soon become one of the main alternative or complementary options in the conventional cancer treatment protocol.

US Bio pharmaceutical Corporation Medolife specializes in research and development of natural cancer fighting drugs and has signed an agreement with Alopecil Laboratory the State certified pharmaceutical company from the Dominican Republic to start production of Escozine, a  medicine approved and certified for Oncological treatments by the state drug administration of the Dominican Republic.

The Nutraceutical uses extracts derived from the Caribbean blue scorpion (Rhopalurus junceus/princeps) that is found natively in the Dominican Republic.  Medolife Corporation concluded a contract in 2008 with the Ministry of Environment of the DR's Wildlife Department to research this specific Buthidae family of scorpions ( Karsch, 1879 ) says president of the Medolife Corp. Dr. Arthur Grant Mikaelian.  Atheris laboratory from Switzerland, one of the world leaders  in the study and analysis of crude venoms, define that the venom of Rhopalurus junceus and Rhopalurus princeps both share similar properties and have similar mechanisms of action in cancer cells. Atherises Mass Spectrometry analyses clearly displays signals that are consistent with scorpion venoms with two major sets of masses, the first one located around 3-4 kDa (mainly potassium channel inhibitors) and the second one at 6-8 kDa (mostly sodium channel inhibitors).

Medolife currently prepares new research aimed at demonstrating the advantages of  combining Escozine with several chemotherapy drugs. Clinical observations show that the effectiveness of chemotherapy increases and significantly decreases common side effects. Oncologists from Medolife notice that in some cases when patients develop chemotherapy resistance, adding Escozine to the treatment makes the patient receptive again to chemotherapy.

Medolife now wishes to research this phenomenon with well known chemotherapy drugs like "Avastin" "Taxol" "Cisplatin" and "5-Fluoracil".

Up till now, the natural medicine has only been available in Cuba, where it is known as Escozul but Medolife`s patent pending polarization technique increases the delivery of the scorpion venom into cancer cells by 58% which amplifies the effectiveness of Escozine dramatically compared to Escozul.